Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States

Journal of Surgical Oncology

Volumn 97, Issue 2, 2008, Pages 103-107

  Chan, John K ^a   Zhang, Mallory ^a   Hu, Jessica M ^a   Shin, Jacob Y ^a   Osann, Kathryn ^b   Kapp, Daniel S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Disparities; Ovarian cancer; Race

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; EPITHELIUM TUMOR; FEMALE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; TREATMENT OUTCOME; UNITED STATES;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, PAPILLARY; DISEASE-FREE SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POPULATION SURVEILLANCE; PROGNOSIS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 38649105490     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20932     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-130.
2. Chan JK, Urban R, Cheung MK, et al.: Ovarian cancer in younger vs older women: A population-based analysis. Br J Cancer 2006; 95:1314-1320.
3. Wingo PA, Bolden S, Tong T, et al.: Cancer statistics for African-Americans. CA Cancer J Clin 1996;46:113-125.
4. Maxwell GL, Tian C, Risinger J, et al.: Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: A Gynecologic Oncology Group study. Cancer 2006;107: 2197-2205.
5. Morris AM, Wei Y, Birkmeyer NJ, et al.: Racial disparities in late survival after rectal cancer surgery. J Am Coll Surg 2006;203: 787-794.
6. Howe HL, Tung KH, Coughlin S, et al.: Race/ethnic variations in ovarian cancer mortality in the United States, 1992-1997. Cancer 2003;97:2686-2693.
7. Mink PJ, Sherman ME, Devesa SS: Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998. Cancer 2002;95:2380-2389.
8. Parham G, Phillips JL, Hicks ML, et al.: The National Cancer Database report on malignant epithelial ovarian carcinoma in African-American women. Cancer 1997;80:816-826.
9. Barnholtz-Sloan JS, Tainsky MA, Abrams J, et al.: Ethnic differences in survival among women with ovarian carcinoma. Cancer 2002;94:1886-1893.
10. McGuire V, Herrinton L, Whittemore AS: Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization. Epidemiology 2002;13:231-234.
11. McGuire V, Jesser CA, Whittemore AS: Survival among U.S. women with invasive epithelial ovarian cancer. Gynecol Oncol 2002;84:399-403.
12. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 12 Regs Public-Use, Nov 2004 Sub (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005.
13. Kosary CL: FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973-87SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 1994;10:31-46.
14. Hill HA, Eley JW, Harlan LC, et al.: Racial differences in endometrial cancer survival: The black/white cancer survival study. Obstet Gynecol 1996;88:919-926.
15. Chan JK, Loizzi V, Lin YG, et al.: Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: What prognostic factors are important? Obstet Gynecol 2003; 102:156-161.
16. Chan JK, Munro EG, Cheung MK, et al.: Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol 2007;109:12-19.
17. Panici PB, Maggioni A, Hacker N, et al.: Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial. J Natl Cancer Inst 2005;97:560-566.
18. Aletti GD, Dowdy S, Podratz KC, et al.: Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Am J Obstet Gynecol 2006;195:1862-1868.
19. Hankey BF, Ries LA, Edwards BK: The surveillance, epidemiology, and end results program: A national resource. Cancer Epidemiol Biomarkers Prev 1999;8:1117-1121.
20. North American Association of Central Cancer Registries. Available at http://www.naaccr.org.
21. Virnig BA, Warren JL, Cooper GS, et al.: Studying radiation therapy using SEER-Medicare-linked data. Med Care 2002; 40:IV-49-54.
22. Cooper GS, Virnig B, Klabunde CN, et al.: Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002; 40:IV-43-48.